The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study

INTRODUCTION: Saxagliptin is a potent, reversible inhibitor of dipeptidyl peptidase-4 that is indicated for the treatment of type 2 diabetes. The DIAPAZON study was a multicenter observational study intended to document the effectiveness, safety and patterns of saxagliptin use in France, including t...

Descripción completa

Detalles Bibliográficos
Autores principales: Balkau, Beverley, Charbonnel, Bernard, Penfornis, Alfred, Chraibi, Nora, Lahouegue, Amir, Faure, Céline, Thomas-Delecourt, Florence, Detournay, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630565/
https://www.ncbi.nlm.nih.gov/pubmed/28948519
http://dx.doi.org/10.1007/s13300-017-0311-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630565/
https://www.ncbi.nlm.nih.gov/pubmed/28948519
http://dx.doi.org/10.1007/s13300-017-0311-2

Ejemplares similares